ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
NCT07388628 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-02-09
Summary
The objectives of this registry study are to:
1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects.
2. Further evaluate ARTICE® treatment efficacy.
3. Identify potential sub-groups, assess their risk-benefit- and safety profile.
4. Changes in SOFA score D0 to SOFA Score D7.
Conditions
- Sepsis
- Septic Shock
- Immunoparalysis in Septic Shock
Sponsors & Collaborators
-
Artcline GmbH
lead INDUSTRY
Principal Investigators
-
Martin Sauer, Prof. Dr. med. · Klinikum Magdeburg, Klinik für Intensiv- & Rettungsmedizin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-25
- Primary Completion
- 2027-09-30
- Completion
- 2027-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Observational Trial on Cytokine Adsorption in Sepsis
NCT04306419 ·Status: UNKNOWN
-
Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)
NCT00386425 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842 ·Status: UNKNOWN
-
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
NCT00879606 ·Status: COMPLETED ·Phase: PHASE2
-
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
NCT04103281 ·Status: RECRUITING
-
NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification
NCT06141395 ·Status: COMPLETED
-
Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock
NCT00252915 ·Status: COMPLETED ·Phase: PHASE2
-
Early Prediction of Sepsis
NCT04570618 ·Status: COMPLETED ·Phase: NA
-
Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms
NCT03379896 ·Status: UNKNOWN
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
NCT07215702 ·Status: RECRUITING ·Phase: PHASE2
-
Continuous Spinal Anesthesia Versus General Anesthesia in Sepsis
NCT05897151 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
NCT00045760 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
Early Detection of Glycocalyx Damage in Emergency Room Patients
NCT03126032 ·Status: COMPLETED
-
German Lactat Clearance in Severe Sepsis
NCT01929772 ·Status: COMPLETED
-
A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
NCT03332225 ·Status: COMPLETED ·Phase: PHASE2
-
Personalized Immunotherapy in Sepsis
NCT04990232 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
A Study on How the Immune System Responds to Sepsis and Its Long-term Effects
NCT07273344 ·Status: RECRUITING
-
Characterization of the Inflammatory Profile of Patients With Macrophage Activation Syndrome Secondary to Bacterial Sepsis
NCT03721809 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING